Science Explorer Interactive view Map
Company · South San Francisco · United States

Mateon Therapeutics (United States)

mateon.comROR OpenAlex
Research works
23
▲ 301% vs 2013–17
Citations
384
17.0 per fractional work
Top-10% rate
23.0%
record average 16.5%
Open access
29%
world 28%

Not ranked overall: Mateon Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which keywords describe research at Mateon Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Stem Cells, Mechanotransduction, Cell Proliferation, Hippo Pathway, YAP/TAZ, Treatment and Genetic Mutations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 16 words, with their numbers
  1. Cancer10▲ 32×6 topics
  2. Stem Cells10▲ 150×4 topics
  3. Mechanotransduction10▲ 429×2 topics
  4. Cell Proliferation10▲ 472×2 topics
  5. Hippo Pathway10▲ 3393×1 topic
  6. YAP/TAZ10▲ 3393×1 topic
  7. Treatment2▲ 7.6×4 topics
  8. Genetic Mutations2▲ 15×5 topics
  9. Immunotherapy2▲ 12×7 topics
  10. Therapy1▲ 30×2 topics
  11. Diagnosis1▲ 5.8×2 topics
  12. Epidemiology1▲ 1.35×4 topics
  13. Cardiovascular Disease1▲ 4.1×2 topics
  14. Guidelines1▲ 9.3×1 topic
  15. Heart Failure1▲ 9.8×1 topic
  16. Quality of Life1▲ 3.4×4 topics

Which research topics does Mateon Therapeutics (United States) publish most on?

By volume in 2022–2025: Hippo pathway signaling and YAP/TAZ, Renal cell carcinoma treatment, PARP inhibition in cancer therapy and Neuroblastoma Research and Treatments.

Hippo pathway signaling …5Hippo pathway signaling and YAP/TAZ: 5 fractional worksRenal cell carcinoma treatment: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksNeuroblastoma Research and Treatments: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksMigraine and Headache Studies: 0 fractional worksSympathectomy and Hyperhidrosis Treatments: 0 fractional worksOphthalmology and Eye Disorders: 0 fractional worksMeningioma and schwannoma management: 0 fractional worksCancer-related gene regulation: 0 fractional works
Cell BiologyPulmonary and Respiratory MedicineOncologyNeurology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Hippo pathway signaling and YAP/TAZ Cell Biology 5 works
  2. 2 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 0 works
  3. 3 PARP inhibition in cancer therapy Oncology 0 works
  4. 4 Neuroblastoma Research and Treatments Neurology 0 works
  5. 5 Immune Cell Function and Interaction Immunology 0 works
  6. 6 Migraine and Headache Studies Psychiatry and Mental health 0 works
  7. 7 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
  8. 8 Ophthalmology and Eye Disorders Pathology and Forensic Medicine 0 works
  9. 9 Meningioma and schwannoma management Epidemiology 0 works
  10. 10 Cancer-related gene regulation Molecular Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available29.2%not open70.8%

World: 28% of research is openly available.

with international co-authors17.1%domestic only82.9%

World: 19% is written across borders.

How has Mateon Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 301% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.